Szmigielski A, Kowner A
Arch Int Pharmacodyn Ther. 1984 Dec;272(2):205-13.
The effect of various doses of apomorphine on the activity of specific endogenous inhibitor of cAMP dependent protein kinase (type I inhibitor) was studied. Apomorphine produced biphasic changes in the type I inhibitor activity in rat striatum. Small doses (50-100 micrograms/kg) induced an increase while large doses (0.5-10 mg/kg) caused a dose dependent decrease of the type I inhibitor activity. The apomorphine induced increase in type I inhibitor activity was completely blocked by small, presynaptically active doses of haloperidol and chlorpromazine and by aminophylline. This suggests that small doses of apomorphine stimulate presynaptic dopamine D2-receptors. In contrast, the apomorphine induced decrease of the type I inhibitor activity was greatly potentiated by aminophylline and by presynaptically active doses of the neuroleptics, suggesting a postsynaptic site of action for large doses of apomorphine. Determination of the type I inhibitor activity is proposed as one of the biochemical tests allowing to recognize the site of action of drugs stimulating dopamine receptors.
研究了不同剂量的阿扑吗啡对环磷酸腺苷依赖性蛋白激酶特异性内源性抑制剂(I型抑制剂)活性的影响。阿扑吗啡使大鼠纹状体中I型抑制剂活性产生双相变化。小剂量(50 - 100微克/千克)引起活性增加,而大剂量(0.5 - 10毫克/千克)导致I型抑制剂活性呈剂量依赖性降低。阿扑吗啡诱导的I型抑制剂活性增加被小剂量、突触前有活性的氟哌啶醇和氯丙嗪以及氨茶碱完全阻断。这表明小剂量阿扑吗啡刺激突触前多巴胺D2受体。相反,阿扑吗啡诱导的I型抑制剂活性降低被氨茶碱和突触前有活性剂量的抗精神病药物大大增强,提示大剂量阿扑吗啡的作用位点在突触后。建议将I型抑制剂活性的测定作为识别刺激多巴胺受体药物作用位点的生化试验之一。